Stefan Vermeulen

Dr. Stefan Vermeulen

Research Center Health & Water Technology
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2003 in Nature Genetics
Verified
Journal Article
Open access
PDF file
CDCatherine Dodé
Catherine Dodé
JLJacqueline Levilliers
Jacqueline Levilliers
JDJean-Michel Dupont
Jean-Michel Dupont
APAnne De Paepe
Anne De Paepe
NDNathalie Le Dû
Nathalie Le Dû
JHJean-Pierre Hardelin
Jean-Pierre Hardelin
We took advantage of overlapping interstitial deletions at chromosome 8p11–p12 in two individuals with contiguous gene syndromes and defined an interval of roughly 540 kb associated with a dominant form of Kallmann syndrome, KAL2. We establish here that loss-of-function mutations in FGFR1 underlie KAL2 whereas a gain-of-function mutation in FGFR1 has been shown to cause a form of craniosynostosis. Moreover, we suggest that the KAL1 gene product, the extracellular matrix protein anosmin-1, is involved in FGF signaling and propose that the gender difference in anosmin-1 dosage (because KAL1 partially escapes X inactivation) explains the higher prevalence of the disease in males.

17 October 2004 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
JHJan Hellemans
Jan Hellemans
OPOlena Preobrazhenska
Olena Preobrazhenska
AWAndy Willaert
Andy Willaert
PDPhilippe Debeer
Philippe Debeer
PVPeter C M Verdonk
Peter C M Verdonk
GMGeert R Mortier
Geert R Mortier

5 January 2021 in Viruses
Verified
Journal Article
Open access
PDF file
DLDavid Lebeaux
David Lebeaux
MMMaia Merabishvili
Maia Merabishvili
ECEric Caudron
Eric Caudron
DLDamien Lannoy
Damien Lannoy
LSLeen Van Simaey
Leen Van Simaey
Mario VaneechoutteMario Vaneechoutte
Mario Vaneechoutte
Bacteriophages are a promising therapeutic strategy among cystic fibrosis and lung-transplanted patients, considering the high frequency of colonization/infection caused by pandrug-resistant bacteria. However, little clinical data are available regarding the use of phages for infections with Achromobacter xylosoxidans. A 12-year-old lung-transplanted cystic fibrosis patient received two rounds of phage therapy because of persistent lung infection with pandrug-resistant A. xylosoxidans. Clinical tolerance was perfect, but initial bronchoalveolar lavage (BAL) still grew A. xylosoxidans. The patient’s respiratory condition slowly improved and oxygen therapy was stopped. Low-grade airway colonization by A. xylosoxidans persisted for months before samples turned negative. No re-colonisation occurred more than two years after phage therapy was performed and imipenem treatment was stopped. Whole genome sequencing indicated that the eight A. xylosoxidans isolates, collected during phage therapy, belonged to four delineated strains, whereby one had a stop mutation in a gene for a phage receptor. The dynamics of lung colonisation were documented by means of strain-specific qPCRs on different BALs. We report the first case of phage therapy for A. xylosoxidans lung infection in a lung-transplanted patient. The dynamics of airway colonization was more complex than deduced from bacterial culture, involving phage susceptible as well as phage resistant strains.

8 May 2021 in Viruses
Verified
Journal Article
Open access
PDF file
HDHans Duyvejonck
Hans Duyvejonck
MMMaia Merabishvili
Maia Merabishvili
Mario VaneechoutteMario Vaneechoutte
Mario Vaneechoutte
SSSteven de Soir
Steven de Soir
RWRosanna Wright
Rosanna Wright
Stefan VermeulenStefan Vermeulen
Stefan Vermeulen
In Belgium, the incorporation of phages into magistral preparations for human application has been permitted since 2018. The stability of such preparations is of high importance to guarantee quality and efficacy throughout treatments. We evaluated the ability to preserve infectivity of four different phages active against three different bacterial species in five different buffer and infusion solutions commonly used in medicine and biotechnological manufacturing processes, at two different concentrations (9 and 7 log pfu/mL), stored at 4 °C. DPBS without Ca2+ and Mg2+ was found to be the best option, compared to the other solutions. Suspensions with phage concentrations of 7 log pfu/mL were unsuited as their activity dropped below the effective therapeutic dose (6–9 log pfu/mL), even after one week of storage at 4 °C. Strong variability between phages was observed, with Acinetobacter baumannii phage Acibel004 being stable in four out of five different solutions. We also studied the long term storage of lyophilized staphylococcal phage ISP, and found that the titer could be preserved during a period of almost 8 years when sucrose and trehalose were used as stabilizers. After rehydration of the lyophilized ISP phage in saline, the phage solutions remained stable at 4 °C during a period of 126 days.

1 November 1997 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MMM. Mareel
M. Mareel
TBT. Boterberg
T. Boterberg
VNV. Noë
V. Noë
LHL. Van Hoorde
L. Van Hoorde
Stefan VermeulenStefan Vermeulen
Stefan Vermeulen
MBM. Bracke
M. Bracke

1 August 1993 in British Journal of Cancer
Verified
Journal Article
Open access
MBMe Bracke
Me Bracke
BVBm Vyncke
Bm Vyncke
EBEa Bruyneel
Ea Bruyneel
Stefan VermeulenStefan Vermeulen
Stefan Vermeulen
GBGk De Bruyne
Gk De Bruyne
MMMm Mareel
Mm Mareel
The calcium-dependent cell-cell adhesion molecule E-cadherin has been shown to counteract invasion of epithelial neoplastic cells. Using three monoclonal antibodies, we have demonstrated the presence of E-cadherin at the surface of human MCF-7/6 mammary carcinoma cells by indirect immunofluorescence coupled to flow cytometry and by immunocytochemistry. Nevertheless, MCF-7/6 cells failed to aggregate in a medium containing 1.25 mM CaCl2, and they were invasive after confrontation with embryonic chick heart fragments in organ culture. Treatment of MCF-7/6 cells with 0.5 microgram ml-1 insulin-like growth factor I (IGF-I) led to homotypic aggregation within 5 to 10 min and inhibited invasion in vitro during at least 8 days. The effect of IGF-I on cellular aggregation was insensitive to cycloheximide. However, monoclonal antibodies that interfered with the function of either the IGF-I receptor (alpha IR3) or E-cadherin (HECD-1, MB2) blocked the effect of IGF-I on aggregation. The effects of IGF-I on aggregation and on invasion could be mimicked by 1 microgram ml-1 insulin, but not by 0.5 microgram ml-1 IGF-II. The insulin effects were presumably not mediated by the IGF-I receptor, since they could not be blocked by an antibody against this receptor (alpha IR3). Our results indicate that IGF-I activates the invasion suppressor role of E-cadherin in MCF-7/6 cells.